OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for September, 2014

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2014-09-30 12:15 GlaxoSmithKline deepens its commitment to 'electroceuticals' and more... 2014-09-30 00:15 AbbVie Tell Shire Employees: The Merger Will Go On and more... 2014-09-29 12:15 AstraZeneca Might Outperform Merck, Bristol-Myers In Cancer Therapy Market and more... 2014-09-26 12:15 Three Take-Home Messages from China's Glaxo Verdict and more... 2014-09-26 00:15 Actavis agrees to keep making original version of its Alzheimer's drug for a while and more... 2014-09-25 12:15 Allergan Declines Valeantâ?Ç?ÿs Olive Branch and more... 2014-09-25 00:15 Shire pays $56.5M to resolve whistleblower claims it improperly marketed drugs and more... 2014-09-24 12:15 Anti-addiction groups call for new FDA chief and more... 2014-09-24 00:15 Salix Receives $100 Million In Patent Infringement Settlement and more... 2014-09-23 12:15 Pharma CEO: Why I Love Twitter and more... 2014-09-23 00:15 Botox maker Allergan rejected Actavis takeover bid and more... 2014-09-22 12:15 FDA authorizes emergency use of Tekmira's Ebola treatment and more... 2014-09-21 12:15 Horizon Pharma moves to Ireland to avoid high US taxes and more... 2014-09-20 12:15 Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA and more... 2014-09-20 00:15 Biotech Sector Continues US Bull Run; Performance Remains Subdued In The EU and more... 2014-09-19 12:15 Pfizer Provides $2M to Support â?Ç?ÿLast-Mileâ?Ç?Ö Vaccine Coverage and more... 2014-09-19 00:15 Valeantâ?Ç?Ös Improving Stock Price Makes Its Allergan Bid Look Better and more... 2014-09-18 12:15 Dealpolitik: Allergan Fight Could Extend Long Past December Meeting and more... 2014-09-18 00:15 Sanofi, MannKind say cutting insulin costs will make Afrezza more competitive and more... 2014-09-17 12:15 Gilead's oncology contender comes up short in pancreatic cancer and more... 2014-09-16 00:15 Xtandi field force to increase by 50% for market-share battle with Zytiga and more... 2014-09-15 12:15 U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks and more... 2014-09-14 12:15 Sanofi aims to grow Genzyme unit with new drugs and acquisitions 2014-09-14 00:15 Pharma Boom: 14 Biosimilars To Debut In The US and more... 2014-09-13 00:15 Gilead to raise price for new hepatitis C drug above $84,000 and more... 2014-09-12 12:15 Abbott, Medtronic named among world's greenest companies and more... 2014-09-12 00:15 Google's stealthy Calico inks an R&D deal for new compounds aimed at neurodegeneration and more... 2014-09-11 12:15 Allergan vs. Valeant: Whereâ?Ç?Ös Perry Mason When You Need Him? and more... 2014-09-11 00:15 FDA Approves Contrave Weight Loss Drug From Orexigen And Takeda and more... 2014-09-10 12:15 New Study Says Common Anxiety Medications Like Xanax, Valium and Klonopin May Increase Risk Of Alzheimer's Disease and more... 2014-09-10 00:15 Actavis Blood Pressure Pill Not Backed by U.S. Advisers and more... 2014-09-09 12:15 Teva Pharmaceuticals New Drug Aims to Reduce Asthma Attacks and more... 2014-09-09 00:15 Single-Dose Flu Drug Shows Promise in Trials and more... 2014-09-08 12:15 Biotech Company Hemispherx Goes Nuts After Announcing Collaboration With US On Ebola Treatment and more... 2014-09-08 00:15 Leading Anti-Marijuana Academics Are Paid By Painkiller Drug Companies 2014-09-07 12:15 Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC and more... 2014-09-07 00:15 Study Shows Immigrants Hold Key Jobs in U.S. Pharma Sector and more... 2014-09-06 12:15 Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint and more... 2014-09-06 00:15 J&J Ordered to Pay $3.27 Million Over Mesh Implant and more... 2014-09-05 12:15 FDA Draft Guidance Could Spur Innovation in Diabetes, Cardio Spaces and more... 2014-09-05 00:15 Gilead Close to Sending $84,000 Drug to Poor Countries and more... 2014-09-04 12:15 [video]Allergan special meeting coming and more... 2014-09-04 00:15 FDA: Little evidence to support testosterone drugs and more... 2014-09-03 12:15 Feds pledge up to $42M to hit the gas on Mapp's Ebola drug and more... 2014-09-03 00:15 Amgen submits melanoma-fighter T-Vec to EMA on the heels of its FDA filing and more... 2014-09-02 12:15 Eli Lilly: Looking To Rule Animal Health Market and more... 2014-09-02 00:15 Novartis drug could be breakthrough in heart failure and more... 2014-09-01 12:15 ThromboGenics spins out cancer R&D, scales down staff amid lackluster Jetrea sales and more... 2014-09-01 00:15 J&J And Bristol-Myers Changing The Myeloma Drug Landscape and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe